Senna

Manufacturer
Safecor Health, LLC
Effective date
2022-12-28
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:42:38

Label at a glance#

ProductSenna
Active ingredientSENNOSIDES
Label structure12 sections

Indications and uses

relieves occasional constipation (irregularity) generally produces a bowel movement in 6-12 hours

Dosage and administration

Take preferably at bedtime or as directed by a doctor Age Starting Dosage Maximum Dosage Adults and children 12 years of age and over 2 tablets once a day 4 tablets twice a day Children 6 to under 12 years 1 tablet once a day 2 tablets twice a day Children 2 to under 6 years ½ tablet once a day 1 tablet twice a day Children under 2 years ask a doctor ask a doctor

Storage and handling

Each tablet contains: calcium 50mg Store at 20°C-25°C (68°F-77°F); excursions permitted between 15°-30°C (59°-86°F)

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Sennosides 8.6mg

Purpose

OTC - PURPOSE SECTION

Laxative

Uses

INDICATIONS & USAGE SECTION

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 6-12 hours

Do not use

OTC - DO NOT USE SECTION

 laxative products for longer than one week unless directed by a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of childen.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental overdose, contact a doctor or Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Take preferably at bedtime or as directed by a doctor
AgeStarting DosageMaximum Dosage
Adults and children 12 years of age and over2 tablets once a day4 tablets twice a day
Children 6 to under 12 years1 tablet once a day2 tablets twice a day
Children 2 to under 6 years½ tablet once a day1 tablet twice a day
Children under 2 yearsask a doctorask a doctor

Other information:

STORAGE AND HANDLING SECTION

  • Each tablet contains: calcium 50mg
  • Store at 20°C-25°C (68°F-77°F); excursions permitted between 15°-30°C (59°-86°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

croscarmellose sodium, dibasic calcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide.

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Senna Tablet

Sennosides 8.6mg

Lot: 22A0161

Exp: 2024-11-22

PKG BY: Safecor Health

Woburn, MA

Rev A

image description
image description

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
48433-13048433-130-01
69168-371

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3a20f3e2-4ca0-4852-869f-42caa3309bedaaa298dc-257a-4593-818a-a0a40a4766bb2024-10-02WarningsExact identifier
spl set id: aaa298dc-257a-4593-818a-a0a40a4766bb
Senna LaxSENNOSIDES 8.6MGAllegiant Health94a9c24a-07c3-4535-b810-b7abc9fc5ad52019-12-11WarningsExact identifier
ndc (product): 69168-371

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.